These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia. Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660 [TBL] [Abstract][Full Text] [Related]
48. Management of gestational trophoblastic diseases in Japan--a review. Sasaki S Placenta; 2003 Apr; 24 Suppl A():S28-32. PubMed ID: 12842411 [TBL] [Abstract][Full Text] [Related]
49. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles. Sato A; Usui H; Shozu M Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360 [TBL] [Abstract][Full Text] [Related]
50. A review on management of gestational trophoblastic neoplasia. Sharami SRY; Saffarieh E J Family Med Prim Care; 2020 Mar; 9(3):1287-1295. PubMed ID: 32509606 [TBL] [Abstract][Full Text] [Related]